Madrigal Pharmaceuticals, Inc.

US$399.63As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:MDGLHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 37.45%
Div yield —
ROE (24.82%)
Biotechnology
Beta (5Y) (1.00)
PE TTM —
TSR TTM (4.60%)
Mkt cap US$9.283B
ROIC (9.77%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$380
(4.96%)
(62.24%)
Hold 4|6|7|10|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
4.77
4.57
4.59
5.07
13.81%
11.41%
0.75%
4.15%
Revenue$M
524.6
533.0
537.2
567.8
7.90%
8.99%
5.05%
6.40%
Peers (US$9.283B)
Cap (US$)
PE
9.152B
—
8.916B
40.87x
Capital
TTM
5Y
10Y
Leveragex
0.255
0.951
0.681
EBIT/Intx
7.615
0.489
0.485
Own earn%
165.02
80.90
58.54
Sh yield%
29.92
50.66
45.83
Owners
Insiders/Inst%
14.94
49.17
Short interest%
3.95
SBC / revenue%
1.72
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
4–19
$1 testx
—
Incr. ROIC%
5